Cannabis Consumption Methods & Harm Reduction Switzerland
The central guide to every cannabis consumption method in Switzerland: smoking, vaporizing, edibles, sublingual tinctures, topicals and dabbing — with onset, bioavailability, risk profile, dosing principles, driving rules and emergency signals. Curated from FOPH, Addiction Switzerland and WHO recommendations.
- Documented methods
- 6
- Fastest onset
- Smoking (joint / pipe) · 1–5 min
- Longest duration
- Edibles / baked goods · 6–10 h
- Lowest-risk profile
- Topical (balms / creams)
All consumption methods compared
| Method | Onset | Peak | Duration | Bioavailability | Risk score |
|---|---|---|---|---|---|
| Smoking (joint / pipe) | 1–5 min | 15–30 min | 2–4 h | 10–35 % | 5 |
| Vaporizing (flower / concentrate) | 1–5 min | 10–20 min | 2–4 h | 25–50 % | 2 |
| Edibles / baked goods | 30–120 min | 120–240 min | 6–10 h | 4–20 % | 4 |
| Sublingual (tincture / oil) | 15–45 min | 60–120 min | 4–8 h | 12–35 % | 2 |
| Topical (balms / creams) | 15–60 min | 60–180 min | 2–6 h | < 1 % systemisch | 1 |
| Dabbing (concentrates > 60 %) | < 1 min | 5–15 min | 1–3 h | 30–50 % | 5 |
1 = lowest harm potential, 5 = highest
Detail by method
Smoking (joint / pipe)
5/5- Onset:
- 1–5 min
- Peak:
- 15–30 min
- Duration:
- 2–4 h
- Bio:
- 10–35 %
Primary risk: Combustion by-products, tar, CO — higher risk when mixed with tobacco (nicotine dependence).
Best for: No gear required, very fine dose titration possible.
Vaporizing (flower / concentrate)
2/5- Onset:
- 1–5 min
- Peak:
- 10–20 min
- Duration:
- 2–4 h
- Bio:
- 25–50 %
Primary risk: Far fewer combustion by-products; risk from cheap vape carts (vitamin E acetate → EVALI).
Best for: Best balance of quick onset and harm reduction — recommended by FOPH as alternative.
Edibles / baked goods
4/5- Onset:
- 30–120 min
- Peak:
- 120–240 min
- Duration:
- 6–10 h
- Bio:
- 4–20 %
Primary risk: Very delayed onset → over-dosing by re-dosing, panic episodes, no driving for 12–24 h after high dose.
Best for: No lung exposure; precise dosing with 2.5–5 mg THC standardized servings.
Sublingual (tincture / oil)
2/5- Onset:
- 15–45 min
- Peak:
- 60–120 min
- Duration:
- 4–8 h
- Bio:
- 12–35 %
Primary risk: Mild risk profile; precise mg dosing required, otherwise confusion with pure CBD oils possible.
Best for: Standard for medical cannabis in Switzerland (prescription, defined THC/CBD ratio).
Topical (balms / creams)
1/5- Onset:
- 15–60 min
- Peak:
- 60–180 min
- Duration:
- 2–6 h
- Bio:
- < 1 % systemisch
Primary risk: Virtually no psychoactive effect — risks limited to skin reactions and cross-allergies.
Best for: Local applications (muscles, joints, skin); ideal for non-consumers.
Dabbing (concentrates > 60 %)
5/5- Onset:
- < 1 min
- Peak:
- 5–15 min
- Duration:
- 1–3 h
- Bio:
- 30–50 %
Primary risk: Very high THC peaks (up to 90 %) → rapid tolerance, hyperemesis risk (CHS), burns.
Best for: Explicitly not recommended for beginners — advanced users with a defined daily cap only.
Harm reduction principles
Harm reduction accepts use as a reality and aims to minimize harm instead of demanding abstinence. These principles follow Addiction Switzerland, FOPH and the Lower-Risk Cannabis Use Guidelines (Fischer et al. 2022, CMAJ).
Later start
Regular use before age 18 significantly raises risk of psychosis and dependence.
Less often
Daily use doubles dependence risk vs. weekly (NASEM 2017).
Lower THC content
Prefer < 10 % THC products; concentrates > 60 % only with solid experience.
Don't smoke
Vaporization significantly reduces respiratory harm; no tobacco mixing.
Never drive
After use: at least 8 h no driving (inhaled), 24 h after high oral dose.
Individual risks
Abstinence during pregnancy, family history of psychosis, severe cardiovascular disease.
Driving ban & THC behind the wheel
Switzerland applies zero tolerance: from 1.5 µg/L THC in whole blood, an automatic license revocation follows (Art. 31 SVG, Art. 34 VZV). Detection windows differ massively between occasional and regular users.
- Inhaled (joint, vape): 6–24 h unfit to drive, occasionally detectable up to 48 h in blood.
- Oral (edibles, tincture): 12–48 h unfit to drive, delayed and prolonged effect.
- Regular use: urinary THC-COOH detectable up to 30 days → professional testing critical.
- If stopped: make no statement, seek legal counsel before consenting to blood draw.
Dosing principles — Start Low, Go Slow
Conservative rule across every method: begin with the lowest effective dose and wait a full effect cycle before re-dosing.
- 1Inhaled: 1 puff (2.5–5 mg THC), wait 10–15 min, then decide.
- 2Edibles: start at 2.5 mg THC, wait 2 hours — even if 'nothing yet'.
- 3Sublingual (tincture): 2.5–5 mg THC under the tongue, hold 60 sec, wait 45 min.
- 4CBD combinations (1:1 or 2:1 CBD:THC) reduce anxiety and tachycardia side effects.
- 5Never combine alcohol and cannabis (greening-out risk).
Emergency signals & what to do
No fatal overdose from the active compound alone is documented. But panic attacks, vasovagal collapse or hypertensive crises are possible — especially with edibles and concentrates.
- Persistent nausea and cramping abdominal pain relieved by hot showers → CHS (cannabinoid hyperemesis syndrome), seek care.
- Tachycardia > 140/min with chest pain → ambulance 144.
- Panic attack: calm environment, cool water, sniff pepper (α-pinene), CBD 25–50 mg.
- Reduced consciousness after edibles in children or elderly → call 144 immediately.
Swiss emergency 144 · Tox Info Suisse 145 · Addiction Switzerland counselling: 0800 104 104 (free).
Calculate, don't estimate
Our two tools make harm reduction concrete — data-based, free, no signup.
Frequently asked
Q1.What is the safest method?
For systemic effect: vaporization of flower (< 210 °C) — far fewer harmful compounds than smoking with comparable bioavailability. For local effect: topical application.
Q2.How long is THC detectable?
Blood: 6–48 h occasional, up to 7 days regular. Urine (THC-COOH): 3–7 days after single use, up to 30 days chronic. Hair: 90 days.
Q3.How much THC per edible serving in Switzerland?
Pilot products declare 2.5–10 mg THC per serving. Homemade edibles are unpredictable — the #1 cause of cannabis-related ER visits.
Q4.CBD oil legal while driving?
CBD < 1 % THC is legal, but blood traces > 1.5 µg/L expose you to license revocation — full-spectrum oils carry this risk.
Q5.Cannabis + medications?
THC inhibits CYP2C9/3A4 → interactions with anticoagulants (warfarin), antiepileptics, HIV therapy. Always consult a doctor if on prescription drugs.
Q6.At what age is use less risky?
From age 25 — before that the prefrontal cortex is still maturing and THC affects cognitive development.
Primary sources
- FOPH — Cannabis use & risks — FOPH / BAG
- Addiction Switzerland — Cannabis factsheet — Addiction Switzerland
- Fischer et al. — Lower-Risk Cannabis Use Guidelines 2022 — CMAJ
- NASEM — Health Effects of Cannabis 2017 — National Academies (US)
- WHO ECDD — Cannabis Review 41st Report — WHO
- Volkow ND et al. — Adverse Health Effects, NEJM 2014 — NEJM
Compound deep-dive
Consumption-relevant cannabinoids & terpenes
Bioavailability, onset and metabolism differ per compound and consumption form. One deep-dive page per cannabinoid and terpene.
Data & statistics
Open datasets from the Swiss Cannabis Data Center — CC-BY-4.0, sourced and documented.
The next step starts with us
We’re preparing the next drops. Join for free and help build the community.